Revision as of 02:17, 24 August 2023 edit Meodipt (talk \| contribs) Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers 37,223 edits ←Created page with '{{Short description\|Chemical compound}} {{drugbox \| drug_name = 4-Chloro-alpha-PHP \| image = 4-Cl-PHP_structure.png \| legal_CA =Schedule I \| legal_DE = NpSG \| legal_UK = Class B \| C = 16 \| H = 22 \| Cl = 1 \| N = 1 \| O = 1 \| IUPAC_name = 1-(4-chlorophenyl)-2-pyrrolidin-1-ylhexan-1-one \| CAS_number = 2748592-28-9 \| ChemSpiderID = \| PubChem = 137331671 \| smiles = CCCCC(C(=O)C1=CC=C(C=C1)Cl)N2CCCC2 \| StdInChI = 1S/C16H22ClNO/c1-2-3-...'		Revision as of 02:18, 24 August 2023 edit undo Meodipt (talk \| contribs) Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers 37,223 edits No edit summary Next edit →
Line 16: }} '''4-Chloro-alpha-Pyrrolidinohexiophenone''' ('''4-Cl-PHP''') is a [[substituted cathinone]] derivative with [[stimulant]] effects, which has been sold as a [[designer drug]],. It was first officially identified by forensic laboratories in 2016, though anecdotal reports suggest it may have been available several years prior to this.<ref>Liu C, Jia W, Li T, Hua Z, Qian Z. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP. ''Drug Test Anal''. 2017 Aug;9(8):1162-1171. {{doi\|10.1002/dta.2136}} {{pmid\|27863142}}</ref> == See also ==

4-Cl-PHP: Difference between revisions